-
Ripster Makes The Case For Cyclacel On Benzinga's 'Power Hour'
Friday, February 5, 2021 - 3:12pm | 291Bio & Tech Trading Founder Ripy Ghuman — Ripster — explained on Benzinga's "Power Hour" Friday why shares of Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) were trading higher. The Case For Cyclacel: Cyclacel is a biopharmaceutical company that develops...